Search research articles
Contact Us
Filters
Showing results (111-120 of 464) with videos related to
Page
of 47
Sort By:
Antibodies (Basel, Switzerland)
|
October 14, 2020
Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19
Zheng Cai, Mark I Greene, Zhiqiang Zhu, et al.
Microbiological Sciences
|
September 1, 1988
Molecular aspects of reovirus-host cell interaction
J A Cohen, W V Williams, M I Greene
The Year in Immunology
|
January 1, 1989
Molecular analysis of primary T cell involvement in the idiotypic network utilizing immunoglobulin-derived peptides
W V Williams, D B Weiner, M I Greene
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1981
Picosecond primary photoprocesses of bilirubin bound to human serum albumin
B I Greene, A A Lamola, C V Shank
Nature Medicine
|
March 15, 2006
A sensitive and high-throughput assay to detect low-abundance proteins in serum
Hongtao Zhang, Xin Cheng, Mark Richter, et al.
Trends in Biotechnology
|
September 1, 1994
Antibody-structure-based design of pharmacological agents
W C Dougall, N C Peterson, M I Greene
Human Immunology
|
April 1, 1982
Genetics and mode of presentation of antigenic determinants: influence on immunologic responsiveness in transplantation
J S Bromberg, C B Carpenter, M I Greene
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2007
Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors
Keiji Furuuchi, Alan Berezov, Toru Kumagai, et al.
Archives of Internal Medicine
|
December 1, 1991
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily
D A Stevens, S I Greene, O S Lang
Survey of Immunologic Research
|
January 1, 1983
Therapeutic effects of interleukins on radiation-treated antigen-presenting cells in vivo and in vitro
A Tominaga, S Lefort, S Mizel, et al.
Page
of 47
Search research articles
Search
Showing results (111-120 of 464) with videos related to
Sort By:
Page
of 47
Antibodies (Basel, Switzerland)
|
October 14, 2020
Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19
Zheng Cai, Mark I Greene, Zhiqiang Zhu, et al.
Microbiological Sciences
|
September 1, 1988
Molecular aspects of reovirus-host cell interaction
J A Cohen, W V Williams, M I Greene
The Year in Immunology
|
January 1, 1989
Molecular analysis of primary T cell involvement in the idiotypic network utilizing immunoglobulin-derived peptides
W V Williams, D B Weiner, M I Greene
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1981
Picosecond primary photoprocesses of bilirubin bound to human serum albumin
B I Greene, A A Lamola, C V Shank
Nature Medicine
|
March 15, 2006
A sensitive and high-throughput assay to detect low-abundance proteins in serum
Hongtao Zhang, Xin Cheng, Mark Richter, et al.
Trends in Biotechnology
|
September 1, 1994
Antibody-structure-based design of pharmacological agents
W C Dougall, N C Peterson, M I Greene
Human Immunology
|
April 1, 1982
Genetics and mode of presentation of antigenic determinants: influence on immunologic responsiveness in transplantation
J S Bromberg, C B Carpenter, M I Greene
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2007
Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors
Keiji Furuuchi, Alan Berezov, Toru Kumagai, et al.
Archives of Internal Medicine
|
December 1, 1991
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily
D A Stevens, S I Greene, O S Lang
Survey of Immunologic Research
|
January 1, 1983
Therapeutic effects of interleukins on radiation-treated antigen-presenting cells in vivo and in vitro
A Tominaga, S Lefort, S Mizel, et al.
Page
of 47